Medical device company Zimmer Biomet Holdings Inc. (NYSE: ZBH) has acquired biotechnology company CD Diagnostics. The two companies originally partnered together in 2012 as a part of a co-development and marketing deal. Financial terms of the purchase were not disclosed.
CD Diagnostics develops medical tests that are designed to improve treatments related to joint infections. The Claymont, Delaware-based target is known for the Synovasure brand, which is used by more than 2,000 surgeons.